BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7681187)

  • 1. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current.
    Cua M; Veltri EP
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):382-6. PubMed ID: 7681187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
    J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients.
    Chen X; Shenasa M; Borggrefe M; Block M; Hindricks G; Martinez-Rubio A; Haverkamp W; Willems S; Böcker D; Mäkijärvi M
    Eur Heart J; 1994 Jan; 15(1):76-82. PubMed ID: 8174587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ventricular fibrillation versus monomorphic ventricular tachycardia during programmed stimulation. Role of premature beat conduction delay.
    Avitall B; McKinnie J; Jazayeri M; Akhtar M; Anderson AJ; Tchou P
    Circulation; 1992 Apr; 85(4):1271-8. PubMed ID: 1372847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J; Cabrera JA; Romero J; Rubio JM
    Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
    Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
    Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
    Pires LA; May LM; Ravi S; Parry JT; Lal VR; Nino CL
    Am J Cardiol; 2000 Mar; 85(6):725-8. PubMed ID: 12000047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Roelke M; O'Nunain S; Osswald S; Trouton TG; Harthorne JW; Garan H; Ruskin JN
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):486-91. PubMed ID: 7770372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators.
    Greenberg SL; Mauricio Sánchez J; Cooper JA; Cain ME; Chen J; Gleva MJ; Lindsay BD; Smith TW; Faddis MN
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1067-75. PubMed ID: 17725748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.
    Rüppel R; Schlüter CA; Boczor S; Meinertz T; Schlüter M; Kuck KH; Cappato R
    J Am Coll Cardiol; 1998 Nov; 32(6):1724-30. PubMed ID: 9822102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG; Stanton MS; Benditt DG; Trusty J; Collins J
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.